Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive

NCT04605952 is registered in ClinicalTrials.gov with Tata Main Hospital as lead sponsor.

NCT NCT04605952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04605952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive
Lead sponsor
Tata Main Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2020
Completion date
August 30, 2020
Enrollment
201 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19